Ingalls & Snyder LLC Amgen Inc Transaction History

Ingalls & Snyder LLC

$2.56 Billion
Q3 2024

A detailed history of Ingalls & Snyder LLC transactions in Amgen Inc stock. As of the latest transaction made, Ingalls & Snyder LLC holds 15,460 shares of AMGN stock, worth $4.55 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares

15,460

Previous 15,410 0.32%

Holding current value

$4.55 Million

Previous $4.82 Million 3.45%

% of portfolio

0.19%

Previous 0.21%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$309.38 - $337.38 $15,469 - $16,869	50 Added 0.32%	15,460 $4.98 Million
Q2 2024 Jul 31, 2024	SELL	$262.75 - $319.31 $2,890 - $3,512	-11 Reduced 0.07%	15,410 $4.82 Million
Q1 2024 May 13, 2024	SELL	$268.87 - $324.56 $87,382 - $105,482	-325 Reduced 2.06%	15,421 $4.38 Million
Q3 2023 Nov 02, 2023	SELL	$218.65 - $271.46 $3,279 - $4,071	-15 Reduced 0.1%	15,746 $4.23 Million
Q1 2023 May 09, 2023	SELL	$225.79 - $275.2 $23,482 - $28,620	-104 Reduced 0.66%	15,761 $3.81 Million
Q4 2022 Jan 31, 2023	SELL	$229.03 - $291.01 $338,964 - $430,694	-1,480 Reduced 8.53%	15,865 $4.17 Million
Q3 2022 Oct 21, 2022	SELL	$224.46 - $253.15 $1,346 - $1,518	-6 Reduced 0.03%	17,345 $3.91 Million
Q2 2022 Aug 11, 2022	SELL	$230.71 - $256.74 $461 - $513	-2 Reduced 0.01%	17,351 $4.22 Million
Q1 2022 May 09, 2022	BUY	$219.27 - $242.57 $27,408 - $30,321	125 Added 0.73%	17,353 $4.2 Million
Q4 2021 Feb 11, 2022	SELL	$198.88 - $227.6 $2,386 - $2,731	-12 Reduced 0.07%	17,228 $3.88 Million
Q2 2021 Aug 03, 2021	SELL	$233.58 - $259.14 $308,092 - $341,805	-1,319 Reduced 7.11%	17,240 $4.2 Million
Q1 2021 Apr 21, 2021	SELL	$221.91 - $258.6 $114,505 - $133,437	-516 Reduced 2.71%	18,559 $4.62 Million
Q4 2020 Jan 27, 2021	BUY	$216.38 - $257.67 $4.13 Million - $4.92 Million	19,075 New	19,075 $4.39 Million
Q3 2020 Oct 21, 2020	SELL	$234.65 - $260.95 $3 Million - $3.34 Million	-12,796 Closed	0 $0
Q2 2020 Jul 31, 2020	SELL	$197.81 - $242.74 $47,870 - $58,743	-242 Reduced 1.86%	12,796 $3.02 Million
Q1 2020 Apr 22, 2020	BUY	$182.24 - $241.7 $2.38 Million - $3.15 Million	13,038 New	13,038 $2.64 Million
Q4 2019 Jan 15, 2020	SELL	$189.21 - $243.2 $2.55 Million - $3.28 Million	-13,474 Closed	0 $0
Q3 2019 Oct 16, 2019	SELL	$174.11 - $208.62 $174 - $208	-1 Reduced 0.01%	13,474 $2.61 Million
Q2 2019 Jul 11, 2019	SELL	$166.7 - $195.41 $132,693 - $155,546	-796 Reduced 5.58%	13,475 $2.48 Million
Q1 2019 Apr 11, 2019	SELL	$180.87 - $203.88 $35,269 - $39,756	-195 Reduced 1.35%	14,271 $2.71 Million
Q4 2018 Jan 24, 2019	SELL	$178.4 - $208.25 $141,649 - $165,350	-794 Reduced 5.2%	14,466 $2.82 Million
Q3 2018 Oct 24, 2018	SELL	$185.29 - $208.89 $555 - $626	-3 Reduced 0.02%	15,260 $3.16 Million
Q2 2018 Aug 10, 2018	SELL	$166.05 - $186.51 $25,737 - $28,909	-155 Reduced 1.01%	15,263 $2.82 Million
Q1 2018 Apr 17, 2018	BUY	$169.43 - $198.0 $180,612 - $211,068	1,066 Added 7.43%	15,418 $2.63 Million
Q4 2017 Jan 19, 2018	BUY	$168.79 - $188.59 $2.42 Million - $2.71 Million	14,352	14,352 $2.5 Million

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ingalls & Snyder LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ingalls & Snyder LLC with notifications on news.

Account

Ingalls & Snyder LLC Amgen Inc Transaction History